Absci Corporation — Company profile
Healthcare · Biotechnology · United States
Last price 11.13 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.91B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Details
| Name | Absci Corporation |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 140 |
| Founded | 2011 |
| Ipo Date | 2021-07-22 |
| Ceo | Sean McClain |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 16.00 |
| Isin | US00091E1091 |
| Cusip | 00091E109 |
| Cik | 1672688 |
| Sic | 8731 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Sean McClain | Founder, Chief Executive Officer, President and Director |
| Dr. Zachariah Jonasson Ph.D. | Chief Business Officer and Chief Financial Officer |
| Todd Bedrick CPA | Senior Vice President and Chief Accounting Officer |
| Alexander Khan CPA | CVice President of Finance and Head of Investor Relations |
| Shelby Walker J.D. | Chief Legal Officer |
| Jeanne Schreuder M.B.A., SPHR | Senior Vice President of People and Experience |
| Wen Sha | Chief of Staff |
| Dr. Christine Lemke D.V.M., M.B.A., Ph.D. | Senior Vice President of Portfolio and Growth Strategy |
| Dr. Ransi Somaratne FACC, M.B.A., M.D. | Chief Medical Officer |
| Dr. Moetaz B. Albizem M.D. | Senior Vice President of Clinical Operations |
Contact
| Address | 18105 SE Mill Plain Boulevard, Vancouver, Washington 98683, United States |
| Phone | 360 949 1041 |
| Website | https://www.absci.com |